Home > Result Summaries: Compounds > GSK2141795 Result Summaries: GSK2141795 GSKStudy ID Phase Title Summary (Download) 113124 phase 1 An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects with Ovarian Cancer (0 citation(s))
